Skip to main content
PMC home page
Thorax logoLink to Thorax
editorial
. 1995 Feb;50(2):113–115. doi: 10.1136/thx.50.2.113

Neuroendocrine differentiation in lung carcinoma.

B J Addis
PMCID: PMC473889  PMID: 7701446

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addis B. J., Hamid Q., Ibrahim N. B., Fahey M., Bloom S. R., Polak J. M. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. J Pathol. 1987 Oct;153(2):137–150. doi: 10.1002/path.1711530207. [DOI] [PubMed] [Google Scholar]
  2. Aguayo S. M., Miller Y. E., Waldron J. A., Jr, Bogin R. M., Sunday M. E., Staton G. W., Jr, Beam W. R., King T. E., Jr Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med. 1992 Oct 29;327(18):1285–1288. doi: 10.1056/NEJM199210293271806. [DOI] [PubMed] [Google Scholar]
  3. Bensch K. G., Corrin B., Pariente R., Spencer H. Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid. Cancer. 1968 Dec;22(6):1163–1172. doi: 10.1002/1097-0142(196811)22:6<1163::aid-cncr2820220612>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  4. Brambilla E., Veale D., Moro D., Morel F., Dubois F., Brambilla C. Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes. Am J Clin Pathol. 1992 Jul;98(1):88–97. doi: 10.1093/ajcp/98.1.88. [DOI] [PubMed] [Google Scholar]
  5. Carney D. N., Zweig M. H., Ihde D. C., Cohen M. H., Makuch R. W., Gazdar A. F. Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Res. 1984 Nov;44(11):5399–5403. [PubMed] [Google Scholar]
  6. Cuttitta F., Carney D. N., Mulshine J., Moody T. W., Fedorko J., Fischler A., Minna J. D. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. 1985 Aug 29-Sep 4Nature. 316(6031):823–826. doi: 10.1038/316823a0. [DOI] [PubMed] [Google Scholar]
  7. Cutz E. Neuroendocrine cells of the lung. An overview of morphologic characteristics and development. Exp Lung Res. 1982 Nov;3(3-4):185–208. doi: 10.3109/01902148209069653. [DOI] [PubMed] [Google Scholar]
  8. Dingemans K. P., Mooi W. J. Ultrastructure of squamous cell carcinoma of the lung. Pathol Annu. 1984;19(Pt 1):249–273. [PubMed] [Google Scholar]
  9. Gazdar A. F., Zweig M. H., Carney D. N., Van Steirteghen A. C., Baylin S. B., Minna J. D. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res. 1981 Jul;41(7):2773–2777. [PubMed] [Google Scholar]
  10. Gosney J. R., Gosney M. A., Lye M., Butt S. A. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma. Thorax. 1995 Feb;50(2):116–120. doi: 10.1136/thx.50.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gould V. E., Linnoila R. I., Memoli V. A., Warren W. H. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest. 1983 Nov;49(5):519–537. [PubMed] [Google Scholar]
  12. Gould V. E., Wiedenmann B., Lee I., Schwechheimer K., Dockhorn-Dworniczak B., Radosevich J. A., Moll R., Franke W. W. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Am J Pathol. 1987 Feb;126(2):243–257. [PMC free article] [PubMed] [Google Scholar]
  13. Graziano S. L., Mazid R., Newman N., Tatum A., Oler A., Mortimer J. A., Gullo J. J., DiFino S. M., Scalzo A. J. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol. 1989 Oct;7(10):1398–1406. doi: 10.1200/JCO.1989.7.10.1398. [DOI] [PubMed] [Google Scholar]
  14. Hamid Q. A., Addis B. J., Springall D. R., Ibrahim N. B., Ghatei M. A., Bloom S. R., Polak J. M. Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma. Virchows Arch A Pathol Anat Histopathol. 1987;411(2):185–192. doi: 10.1007/BF00712743. [DOI] [PubMed] [Google Scholar]
  15. Hamid Q. A., Corrin B., Dewar A., Hoefler H., Sheppard M. N. Expression of gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung. J Pathol. 1990 Jun;161(2):145–151. doi: 10.1002/path.1711610209. [DOI] [PubMed] [Google Scholar]
  16. Hamid Q., Corrin B., Sheppard M. N., Huttner W. B., Polak J. M. Expression of chromogranin A mRNA in small cell carcinoma of the lung. J Pathol. 1991 Apr;163(4):293–297. doi: 10.1002/path.1711630405. [DOI] [PubMed] [Google Scholar]
  17. Hoog A., Gould V. E., Grimelius L., Franke W. W., Falkmer S., Chejfec G. Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin. Ultrastruct Pathol. 1988 Nov-Dec;12(6):673–678. doi: 10.3109/01913128809056493. [DOI] [PubMed] [Google Scholar]
  18. Kayser K., Schmid W., Ebert W., Wiedenmann B. Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung. Pathol Res Pract. 1988 Aug;183(4):412–417. doi: 10.1016/S0344-0338(88)80087-6. [DOI] [PubMed] [Google Scholar]
  19. Kibbelaar R. E., Moolenaar C. E., Michalides R. J., Bitter-Suermann D., Addis B. J., Mooi W. J. Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer. J Pathol. 1989 Sep;159(1):23–28. doi: 10.1002/path.1711590108. [DOI] [PubMed] [Google Scholar]
  20. Linnoila R. I., Mulshine J. L., Steinberg S. M., Funa K., Matthews M. J., Cotelingam J. D., Gazdar A. F. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988 Dec;90(6):641–652. doi: 10.1093/ajcp/90.6.641. [DOI] [PubMed] [Google Scholar]
  21. Lloyd R. V., Jin L., Kulig E., Fields K. Molecular approaches for the analysis of chromogranins and secretogranins. Diagn Mol Pathol. 1992 Mar;1(1):2–15. doi: 10.1097/00019606-199203000-00002. [DOI] [PubMed] [Google Scholar]
  22. Mooi W. J., Dewar A., Springall D., Polak J. M., Addis B. J. Non-small cell lung carcinomas with neuroendocrine features. A light microscopic, immunohistochemical and ultrastructural study of 11 cases. Histopathology. 1988 Sep;13(3):329–337. doi: 10.1111/j.1365-2559.1988.tb02043.x. [DOI] [PubMed] [Google Scholar]
  23. Said J. W., Vimadalal S., Nash G., Shintaku I. P., Heusser R. C., Sassoon A. F., Lloyd R. V. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol. 1985 Mar;16(3):236–240. doi: 10.1016/s0046-8177(85)80008-3. [DOI] [PubMed] [Google Scholar]
  24. Sheppard M. N. Neuroendocrine differentiation in lung tumours. Thorax. 1991 Nov;46(11):843–850. doi: 10.1136/thx.46.11.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sobol R. E., O'Connor D. T., Addison J., Suchocki K., Royston I., Deftos L. J. Elevated serum chromogranin A concentrations in small-cell lung carcinoma. Ann Intern Med. 1986 Nov;105(5):698–700. doi: 10.7326/0003-4819-105-5-698. [DOI] [PubMed] [Google Scholar]
  26. Sundaresan V., Reeve J. G., Stenning S., Stewart S., Bleehen N. M. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer. 1991 Aug;64(2):333–338. doi: 10.1038/bjc.1991.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Travis W. D., Linnoila R. I., Tsokos M. G., Hitchcock C. L., Cutler G. B., Jr, Nieman L., Chrousos G., Pass H., Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991 Jun;15(6):529–553. doi: 10.1097/00000478-199106000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES